רקומבינאט IU 1000

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Nunua Sasa

Viambatanisho vya kazi:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Inapatikana kutoka:

TEVA MEDICAL MARKETING LTD.

ATC kanuni:

B02BD02

Dawa fomu:

POWDER FOR SOLUTION FOR INJECTION

Njia ya uendeshaji:

I.V

Viwandani na:

BAXTER S.A., BELGIUM

Kundi la matibabu:

COAGULATION FACTOR VIII

Matibabu dalili:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Idhini ya tarehe:

2010-07-01